Blog – Full Width

Shares of Gilead Sciences Inc.’s stock gained 2.1% in after-hours trading on Thursday after the drug maker surprised investors with better-than-expected sales of its COVID-19 drug Veklury during the fourth quarter of 2020.

Peloton Interactive Inc. notched its first-ever quarter with revenue above $1 billion, but its shares sank in after-hours trading after the company’s investments in shipping and other areas meant to address delivery delays weighed on its earnings outlook for the current period.